| Dr Travis Kotter, DPM | |
|
4190 E Woodmen Rd Ste 100, Colorado Springs, CO 80920 | |
| (719) 632-4455 | |
| Not Available |
| Full Name | Dr Travis Kotter |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 8 Years |
| Location | 4190 E Woodmen Rd Ste 100, Colorado Springs, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457746844 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 0000845 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centura Health-penrose St Francis Health Services | Colorado springs, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Matthews-vu Medical Group, P.c. | 3072790864 | 40 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of a new virtual journal: Atlas. Published as a virtual journal, Atlas selects already published research on topics that hold high societal relevance or address global issues, and summarizes and presents the science in a lay-friendly, story format to reach an as wide as possible global audience.
Solta Medical, Inc. (Nasdaq: SLTM) is proud to celebrate the launch of the new Thermage CPT and Fraxel re:store Dual systems with the kick off of the illumiNATION tour (www.illumiNATIONtour.com). Starting September 14 and continuing through November, the illumiNATION tour is bringing the latest breakthroughs in Thermage(R) and Fraxel(R) systems directly to physicians in over 20 cities across the U.S. and 11 cities in Europe.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the initiation of a confirmatory Phase 3 clinical trial to further evaluate otelixizumab in autoimmune new-onset type 1 diabetes. The confirmatory Phase 3 clinical trial is called DEFEND-2 (Durable-Response Therapy Evaluation For Early or New-Onset Type 1 Diabetes) and immediately follows successful completion of enrollment in the initial Phase 3 clinical trial, DEFEND-1, with results from DEFEND-1 expected in the first half of 2011.
A team of scientists from the UNC School of Medicine and North Carolina State University has developed promising research towards a possible stem cell treatment for several lung conditions, such as idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and cystic fibrosis - often-fatal conditions that affect tens of millions of Americans.
In a study of 15 patients affected by major depressive disorder and complaining of insomnia, initiating treatment with vortioxetine for their depressive symptoms led to significant improvements in subjective sleep quality and daytime sleepiness.
› Verified 1 days ago
| Provider Name | Matthews-vu Medical Group, P.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1649438433 PECOS PAC ID: 3072790864 Enrollment ID: O20110603000138 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of a new virtual journal: Atlas. Published as a virtual journal, Atlas selects already published research on topics that hold high societal relevance or address global issues, and summarizes and presents the science in a lay-friendly, story format to reach an as wide as possible global audience.
Solta Medical, Inc. (Nasdaq: SLTM) is proud to celebrate the launch of the new Thermage CPT and Fraxel re:store Dual systems with the kick off of the illumiNATION tour (www.illumiNATIONtour.com). Starting September 14 and continuing through November, the illumiNATION tour is bringing the latest breakthroughs in Thermage(R) and Fraxel(R) systems directly to physicians in over 20 cities across the U.S. and 11 cities in Europe.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the initiation of a confirmatory Phase 3 clinical trial to further evaluate otelixizumab in autoimmune new-onset type 1 diabetes. The confirmatory Phase 3 clinical trial is called DEFEND-2 (Durable-Response Therapy Evaluation For Early or New-Onset Type 1 Diabetes) and immediately follows successful completion of enrollment in the initial Phase 3 clinical trial, DEFEND-1, with results from DEFEND-1 expected in the first half of 2011.
A team of scientists from the UNC School of Medicine and North Carolina State University has developed promising research towards a possible stem cell treatment for several lung conditions, such as idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and cystic fibrosis - often-fatal conditions that affect tens of millions of Americans.
In a study of 15 patients affected by major depressive disorder and complaining of insomnia, initiating treatment with vortioxetine for their depressive symptoms led to significant improvements in subjective sleep quality and daytime sleepiness.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Travis Kotter, DPM 4190 E Woodmen Rd Ste 100, Colorado Springs, CO 80920-8075 Ph: (719) 632-4455 | Dr Travis Kotter, DPM 4190 E Woodmen Rd Ste 100, Colorado Springs, CO 80920 Ph: (719) 632-4455 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of a new virtual journal: Atlas. Published as a virtual journal, Atlas selects already published research on topics that hold high societal relevance or address global issues, and summarizes and presents the science in a lay-friendly, story format to reach an as wide as possible global audience.
Solta Medical, Inc. (Nasdaq: SLTM) is proud to celebrate the launch of the new Thermage CPT and Fraxel re:store Dual systems with the kick off of the illumiNATION tour (www.illumiNATIONtour.com). Starting September 14 and continuing through November, the illumiNATION tour is bringing the latest breakthroughs in Thermage(R) and Fraxel(R) systems directly to physicians in over 20 cities across the U.S. and 11 cities in Europe.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the initiation of a confirmatory Phase 3 clinical trial to further evaluate otelixizumab in autoimmune new-onset type 1 diabetes. The confirmatory Phase 3 clinical trial is called DEFEND-2 (Durable-Response Therapy Evaluation For Early or New-Onset Type 1 Diabetes) and immediately follows successful completion of enrollment in the initial Phase 3 clinical trial, DEFEND-1, with results from DEFEND-1 expected in the first half of 2011.
A team of scientists from the UNC School of Medicine and North Carolina State University has developed promising research towards a possible stem cell treatment for several lung conditions, such as idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and cystic fibrosis - often-fatal conditions that affect tens of millions of Americans.
In a study of 15 patients affected by major depressive disorder and complaining of insomnia, initiating treatment with vortioxetine for their depressive symptoms led to significant improvements in subjective sleep quality and daytime sleepiness.
› Verified 1 days ago
Dr. Matthew Diehl Hinderland, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1465 Kelly Johnson Blvd Ste 100, Colorado Springs, CO 80920 Phone: 719-488-4664 Fax: 719-488-4667 | |
Foot And Ankle Institute Of Colorado, Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 1465 Kelly Johnson Blvd Ste 100, Colorado Springs, CO 80920 Phone: 719-488-4664 Fax: 719-488-4667 | |
Mcvay Foot & Ankle, Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 6160 Tutt Blvd, Ste 150, Colorado Springs, CO 80923 Phone: 719-266-5000 Fax: 719-266-6596 | |
Dr. Tim Carlsen, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2620 Tenderfoot Hill St, Suite 10, Colorado Springs, CO 80906 Phone: 719-576-2080 Fax: 719-576-2248 | |
Candice Cooper, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 8580 Scarborough Dr Ste 120, Colorado Springs, CO 80920 Phone: 719-266-5000 Fax: 719-266-6596 | |
Dr. Matthew Reed Thomas, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2620 Tenderfoot Hill St Ste 200, Colorado Springs, CO 80906 Phone: 719-867-8838 | |
Dr. Trevor Keith Whiting, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1465 Kelly Johnson Blvd Ste 100, Colorado Springs, CO 80920 Phone: 719-488-4664 Fax: 719-488-4667 |